CaaMTech

  • Updates
  • Our Team
  • About
  • Contact

Updates

March 14, 2023

CaaMTech Synthesizes and Characterizes Monoalkyl Tryptamine 4-HO-NiPT

4-HO-NiPT is an active metabolite of 4-HO-DiPT and closely related to norpsilocin

November 15, 2022

Psilacetin is More Potent than Psilocybin, Study Shows

Researchers directly compared psilocybin with understudied magic mushroom molecules, and synthetic analogs such as psilacetin

September 22, 2022

CaaMTech Creates Two New Prodrugs of 4-HO-DiPT

4-HO-DiPT has been proposed as a more clinically-optimized alternative to psilocybin

September 14, 2022

CaaMTech Publishes Fundamental Research on Aeruginascin Derivatives

Aeruginascin is a naturally-occurring quaternary tryptammonium compound found in Magic Mushrooms

July 6, 2022

CaaMTech Collaborates with the Alexander Shulgin Research Institute to Study Shulgin Compounds

CaaMTech will help carry on Dr. Alexander Shulgin’s legacy by developing ASRI’s novel compounds

CaaMTech and CaaMTech Collaborates with the Alexander Shulgin Research Institute Logos

June 15, 2022

Mike O’Shaughnessy Joins CaamTech as General Counsel and Director of Intellectual Property

O’Shaughnessy brings decades of experience in intellectual property strategy, collaborations, and development within the life sciences and pharmaceutical industries

June 2, 2022

CaaMTech Collaboration Proves Diversity in Magic Mushroom Chemistry

A new paper published by The Leibniz Institute for Natural Product Research in collaboration with CaaMTech reveals the complex chemistry of magic mushrooms

May 9, 2022

“Minor” Magic Mushroom Compound Crystal Structure Solved

CaaMTech collaborates with UMass Dartmouth to solve crystal structure of overlooked baeocystin

A ball and stick model of the chemical structure of baeocystin

March 15, 2022

CaaMTech Solves Serotonin Crystal Structure

CaaMTech scientists have solved the crystal structure of freebase serotonin for the first time

A diagram showing the molecular structure of serotonin

February 17, 2022

Bob Discordia Joins CaaMTech as Chief Scientific Officer

Dr. Discordia brings over 30 years of pharmaceutical industry experience to CaaMTech

Posts navigation

← older
CaamTech
  • LinkedIn
  • Facebook
  • Twitter
  • CaaMTech
    • Contact
    • About CaaMTech
    • Updates

Get CaaMTech Updates in your Inbox

© Copyright 2023 CaaMTech. All rights reserved.